Investigation of novel biomarkers and therapeutics

  • Research type

    Research Study

  • Full title

    Collecting high-quality biomaterial from patients with nerodegenerative diseases and controls for diagnostic and prognostic biomarker investigation/validation, therapeutic applications and other research activities.

  • IRAS ID

    355533

  • Contact name

    Ramin Nilforooshan

  • Contact email

    ramin.nilforooshan@sabp.nhs.uk

  • Sponsor organisation

    Vesalic

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    The study aims to investigate the potential causes and mechanisms of neurodegenerative diseases focusing on the development of predictive, diagnostic and prognostic biomarkers, and potential therapeutic targets. Participants with neurodegenerative diseases such as Alzheimer's disease, Frontotemporal dementia, dementia with Lewy bodies, Parkinson's disease and Amyotrophic Lateral Sclerosis will be included in the study together with healthy controls.

  • REC name

    Wales REC 7

  • REC reference

    25/WA/0178

  • Date of REC Opinion

    4 Jun 2025

  • REC opinion

    Favourable Opinion